Atara Biotherapeutics, Price Chart
Atara Biotherapeutics, Volume Chart
Atara Biotherapeutics, Market Segments
After Hours
+0.00(+0.00%)
| Open | $9.96 |
|---|---|
| Close | $9.96 |
| Low | $9.96 |
| Low Change | 0.00 (0.00%) |
| High | $9.96 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 2.912K |
| Dollar Volume | $29.00K |
Regular Trading Hours
-0.54(-5.11%)
| Open | $10.50 |
|---|---|
| Close | $9.96 |
| Low | $9.85 |
| Low Change | -0.65 (-6.19%) |
| High | $10.92 |
| High Change | +0.42 (+4.00%) |
| Range | $1.07 |
| Volume | 72.801K |
| Dollar Volume | $725.32K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $10.41 |
|---|---|
| Close | $10.41 |
| Low | $10.41 |
| Low Change | 0.00 (0.00%) |
| High | $10.41 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 5.048K |
| Dollar Volume | $52.55K |
Regular Trading Hours Yesterday
+0.20(+1.97%)
| Open | $10.14 |
|---|---|
| Close | $10.34 |
| Low | $10.14 |
| Low Change | 0.00 (0.00%) |
| High | $10.99 |
| High Change | +0.85 (+8.38%) |
| Range | $0.85 |
| Volume | 80.5K |
| Dollar Volume | $832.37K |
Premarket Yesterday
*No Trades in Segment
Atara Biotherapeutics, Moving Averages
| 5 Day Moving Average (SMA5) | $10.02 |
|---|---|
| 10 Day Moving Average (SMA10) | $10.03 |
| 20 Day Moving Average (SMA20) | $9.97 |
| 50 Day Moving Average (SMA50) | $7.51 |
| 100 Day Moving Average (SMA100) | $6.29 |
| 200 Day Moving Average (SMA200) | $10.03 |
Atara Biotherapeutics, Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Atara Biotherapeutics, Stock Splits
There has been 1 stock split for Atara Biotherapeutics, (ATRA). The reverse stock split occured on June 20, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 20, 2024 | Reverse | 25:1 |
Atara Biotherapeutics, Dividends
There have been no dividends for Atara Biotherapeutics, (ATRA).